Thymoma
Conditions
Interventions
Balance Hook-Assisted Group:Percutaneous balance hook-assisted subxiphoid uniportal VATS thymectomy
Traditional Surgical Approaches Group:Subxiphoid Three-Port Thoracoscopic Thymectomy, Intercostal Lateral Approach Thymectomy
Sponsors
DepartmeWest China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis of anterior mediastinal mass: At present, surgical resection is the main treatment for anterior mediastinal mass, and the surgical indications are reasonable, so the patients with anterior mediastinal mass diagnosed as the disease were selected as subjects. 2. Patients can understand and cooperate with pain assessment (visual analogue scale) and informed consent: This study intends to use "visual analogue scale" to evaluate the degree of postoperative pain of subjects, so subjects should be able to understand and cooperate with pain assessment. Informed consent is an important ethical standard for conducting clinical trials. It aims to respect the rights and interests of subjects, protect their rights and interests, provide information transparency to subjects, and comply with legal and ethical norms. 3. The lesion did not invade the surrounding organs and large vessels: To investigate the safety and efficacy of "percutaneous subxiphoid uniportal VATS for anterior mediastinal mass" and to compare it with the traditional minimally invasive approach, this study only included patients who underwent VATS alone for anterior mediastinal mass, thymus and surrounding tissue resection. Patients with Masaoka stage ?/? (corresponding to stage ?/? of AJCC staging) thymic tumor without invasion of adjacent organs and metastasis were included in this study. 4. Be over 18 years old. He is an adult, cooperates with treatment and has behavioral judgment. 5. Diameter of anterior mediastinal mass >=2cm. Surgical excision Pointers are available.
Exclusion criteria
Exclusion criteria: 1. Preoperative neoadjuvant therapy: In order to explore the safety and efficacy of "percutaneous subxiphoid uniportal VATS with balance retractor" for anterior mediastinal mass, and to compare with the traditional minimally invasive approach, patients who received neoadjuvant therapy were excluded. 2. Preoperative history of chronic pain and long-term use of opioids and other analgesics: This study intends to use the "visual analogue scale" to evaluate the degree of postoperative pain of the subjects, so the subjects should not have a history of chronic pain and long-term use of opioids and other analgesics; 3. History of median sternotomy: these patients are not suitable for minimally invasive surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical Completion Rate;Postoperative Complication Rate;Operative Time;Intraoperative Blood Loss;Intraoperative Adverse Event Rate;Pain Visual Analog Scale (VAS) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative recovery time;Hospitalization after surgery;Usage of surgical equipment or materials;Reoperation rate;Postoperative drainage volume;Dosage of analgesic medications; | — |
Countries
China
Contacts
Public ContactDong Tian
West China Hospital of Sichuan University
Outcome results
None listed